Balyasny Asset Management
TOI icon

Balyasny Asset Management’s The Oncology Institute TOI Stock Holding History

Balyasny Asset Management’s Portfolio TOI Stock Details TOI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,263,100
Closed -$8.06M – 3532
2025
Q4 		$8.06M Buy
+2,263,100
New +$8.39M 0.01% 1138

Other funds holding TOI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Balyasny Asset Management's TOI Position: Q1 2026 in Review

Balyasny Asset Management reduced its The Oncology Institute (TOI) stake by 27% in Q1 2026, selling an estimated $2.12M and leaving 1,826,370 shares worth $5.61M. The position accounts for 0.01% of the portfolio, ranked #1325.

Balyasny Asset Management first reported a position in TOI in Q1 2022 and has held it in 12 quarters since. The position peaked at $8.97M in Q4 2025. 115 funds tracked by Wall St. Rank hold TOI as of Q1 2026.

  • Balyasny Asset Management held 1,826,370 shares of The Oncology Institute worth $5.61M as of Q1 2026.
  • Balyasny Asset Management sold 692,067 The Oncology Institute shares in Q1 2026, an estimated $2.12M.
  • The Oncology Institute made up 0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1325 holding.
  • Balyasny Asset Management first reported a position in The Oncology Institute in Q1 2022 and has held it in 12 quarters since.
  • Balyasny Asset Management's The Oncology Institute position peaked at $8.97M in Q4 2025.
  • 115 funds tracked by Wall St. Rank held The Oncology Institute as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.